Hybrid Conferencee

International Conference on Lupus and Autoimmune Disorders (ICLAAD - 26)

12th - 13th September 2026 | Dallas, USA

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Dallas. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Dallas event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Dallas conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Dallas, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Dallas."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Lupus Diagnostics

This track will explore the latest innovations in molecular diagnostics for lupus and related autoimmune disorders. Emphasis will be placed on the identification and validation of novel biomarkers that enhance diagnostic accuracy.

Track 02

Translational Research in Autoimmunity

This session will focus on the bridge between laboratory discoveries and clinical applications in the field of autoimmune diseases. Presentations will highlight successful translational research initiatives that have led to improved patient outcomes.

Track 03

Therapeutic Strategies for Lupus Management

This track will examine emerging therapeutic strategies and treatment modalities for managing lupus and its complications. Discussions will include both pharmacological and non-pharmacological approaches to patient care.

Track 04

Immunological Mechanisms in Autoimmune Disorders

This session will delve into the underlying immunological mechanisms that drive lupus and other autoimmune conditions. Research findings will be presented that elucidate the role of immune dysregulation in disease pathogenesis.

Track 05

Clinical Research Methodologies in Rheumatology

This track will address innovative clinical research methodologies tailored for rheumatology studies. Emphasis will be placed on the design, implementation, and analysis of clinical trials in lupus and autoimmune disorders.

Track 06

Patient-Centered Care in Autoimmune Disorders

This session will focus on the importance of patient-centered approaches in the management of lupus and autoimmune diseases. Presentations will highlight strategies for enhancing patient engagement and improving quality of care.

Track 07

Laboratory Innovations in Rheumatology

This track will showcase cutting-edge laboratory techniques and technologies that are transforming the field of rheumatology. Topics will include advancements in diagnostic tools and research methodologies.

Track 08

Biomarker Discovery in Autoimmune Diseases

This session will explore the latest findings in biomarker discovery for lupus and related autoimmune disorders. Researchers will present their work on identifying potential biomarkers for disease diagnosis and monitoring.

Track 09

Epidemiology and Risk Factors of Lupus

This track will investigate the epidemiological aspects and risk factors associated with lupus and autoimmune disorders. Discussions will include population-based studies and their implications for public health.

Track 10

Psychosocial Aspects of Autoimmune Disorders

This session will examine the psychosocial impact of lupus and autoimmune diseases on patients and their families. Research will focus on mental health, coping strategies, and support systems.

Track 11

Future Directions in Rheumatology Research

This track will provide insights into future research directions and emerging trends in the field of rheumatology. Participants will discuss potential breakthroughs and the implications for clinical practice.